Huron Consulting Group Inc. (NASDAQ:HURN) Director Sells $247,380.00 in Stock

Huron Consulting Group Inc. (NASDAQ:HURN) Director James H. Roth sold 2,000 shares of the business’s stock in a transaction on Wednesday, January 8th. The shares were sold at an average price of $123.69, for a total transaction of $247,380.00. Following the transaction, the director now owns 50,534 shares in the company, valued at $6,250,550.46. This trade represents a 3.81 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Huron Consulting Group Trading Down 0.7 %

Shares of NASDAQ HURN traded down $0.82 during mid-day trading on Monday, reaching $123.78. The company had a trading volume of 1,247 shares, compared to its average volume of 78,798. The business’s 50-day moving average is $123.20 and its 200-day moving average is $112.10. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.82. The stock has a market cap of $2.20 billion, a price-to-earnings ratio of 26.91 and a beta of 0.60. Huron Consulting Group Inc. has a 52 week low of $84.26 and a 52 week high of $131.06.

Huron Consulting Group (NASDAQ:HURN) last issued its earnings results on Tuesday, October 29th. The business services provider reported $1.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.11. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The company had revenue of $370.00 million for the quarter, compared to analysts’ expectations of $377.63 million. During the same period in the prior year, the business earned $1.39 EPS. The firm’s quarterly revenue was up 3.3% on a year-over-year basis. Equities analysts expect that Huron Consulting Group Inc. will post 6.1 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on HURN. Benchmark reiterated a “buy” rating and set a $140.00 price objective on shares of Huron Consulting Group in a research report on Wednesday, October 30th. StockNews.com upgraded shares of Huron Consulting Group from a “hold” rating to a “buy” rating in a research report on Thursday, October 31st. Finally, Barrington Research upped their price target on shares of Huron Consulting Group from $137.00 to $142.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $133.00.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Ashton Thomas Private Wealth LLC purchased a new position in shares of Huron Consulting Group in the 2nd quarter valued at approximately $28,000. Assetmark Inc. grew its stake in shares of Huron Consulting Group by 7.0% during the 3rd quarter. Assetmark Inc. now owns 1,373 shares of the business services provider’s stock worth $149,000 after purchasing an additional 90 shares during the period. MML Investors Services LLC acquired a new stake in Huron Consulting Group in the 3rd quarter valued at $220,000. Peapack Gladstone Financial Corp acquired a new stake in Huron Consulting Group in the 3rd quarter valued at $220,000. Finally, Orion Portfolio Solutions LLC acquired a new stake in Huron Consulting Group in the 3rd quarter valued at $264,000. 93.90% of the stock is currently owned by institutional investors.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.